Cite
HARVARD Citation
Fang, Q. et al. (2022). The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia. Blood science. 4 (1), pp. 44-46. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fang, Q. et al. (2022). The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia. Blood science. 4 (1), pp. 44-46. [Online].